An audit of the compliance of Harrogate district hospital's current post vasectomy clearance service  by Jelley, Clare & Davies, Annemarie
Abstracts / International Journal of Surgery 12 (2014) S13eS117 S105Introduction: Flexible cystoscopy (FC) is a common urology procedure;
over 220,000 are performed in UK annually. Urinary tract infection (UTI) is
a potential complication with rates varying from 0.8-10%; most requiring
antibiotic treatment in primary care. There is on-going debate regarding
antibiotic prophylaxis for FC. Our aim was to evaluate the incidence of UTI
following FC in our institution ascertaining whether prophylaxis is indi-
cated. Identify the antibiotic proﬁle of causative organisms to guide
treatment of post-FC UTIs.
Methods: We retrospectively analysed 288 patients who underwent FC
over 3months. Patients were cross-matched with our microbiology results
reporting system (Sunquest-Ice€a) to identify those who had a urine sample
sent for analysis within 30 days of their procedure.
Results: Of the 288 FCs performed 37 patients (12.8%) had a urine sample
sent for microbiology analysis. Twenty-ﬁve were from primary care and 15
from hospital with the median time from FC of 15 days. Ten samples
showed signiﬁcant bacterial growth with E. coli predominating. Most were
sensitive to cefalexin (75%), nitrofurantoin (100%) or trimethoprim (67%).
No organisms had extended antibiotic resistance.
Conclusions: Our incidence of post-FC UTI is 3.47% suggesting prophylaxis
is unwarranted. No extended antibiotic resistance was exhibited therefore
no changes to antibiotic recommendations are required.
0580: RISKS AND ASSOCIATIONS OF FISH-OIL PRODUCTS WITH PROS-
TATE CANCER: A STUDY OF 492,283 PARTICIPANTS
Catherine Lovegrove *, Kamran Ahmed, Hamid Abboudi, Saied Froghi,
Rick Popert, M Shamim Khan, Prokar Dasgupta. King's College London,
London, UK.
Introduction: The role of ﬁsh-oils in inﬂammation entails potential
carcinogenesis inhibition and improved cancer symptoms. This system-
atic-analysis aims to review evidence for the role of dietary-ﬁsh and ﬁsh-
oil intake in prostate-cancer (PC) risk, aggression and mortality.
Methods: A systematic-review of literature on PC-risk, aggression and
mortality associated with dietary-ﬁsh and ﬁsh-oil intake was conducted
through PubMed, MEDLINE and Embase. Outcome-measures (PC-risk,
aggression and mortality) were extracted for analysis.
Results: 492,283 (36-studies) participants were investigated. These
revealed various relationships regarding PC-risk (n¼30), aggression (n¼7)
and mortality (n¼3). Nine studies considering PC-risk demonstrated sig-
niﬁcant inverse trends with ﬁsh or ﬁsh-oil intake. One found a dose-
response relationship whereas increased long-chain-polyunsaturated-
fatty-acids heightened PC-risk (p¼0.014). Three studies identiﬁed a
signiﬁcantly reduced risk of aggressive disease. This applied to greatest
intake of total ﬁsh (OR 0.56 (95% CI 0.37e0.86)), dark-ﬁsh, shellﬁsh-meat
(p<0.0001), EPA (p¼0.03) and DHA (p¼0.04). Three studies investigating
ﬁsh-consumption and PC-mortality identiﬁed signiﬁcant risk reduction.
Multivariate-OR(95% CI); 0.9(0.6-1.7), 0.12(0.05-0.32) and 0.52(0.30-0.91)
at greatest measured ﬁsh-intakes.
Conclusions: Fish and ﬁsh-oil may be important in reducing PC-
incidence, aggression and mortality. Results suggest that ﬁsh type and
ﬁsh-oil ratios are signiﬁcant considerations. Findings demonstrate po-
tential for incorporation into campaigns for primary and secondary
prevention.
0604: AN AUDIT OF THE COMPLIANCE OF HARROGATE DISTRICT HOSPI-
TAL'S CURRENT POST VASECTOMY CLEARANCE SERVICE
Clare Jelley *, Annemarie Davies. Harrogate and District NHS Foundation
Trust, North Yorkshire, UK.
Introduction: A vasectomy is a common procedure and our current
guidelines taken from BAS 2002 require 2 negative sperm samples for
clearance, at 16 and 18 weeks post-operatively. Multiple posted samples
were reported as “scanty”, resulting in further samples needed for clear-
ance. We aim to quantify this enabling us to implement change to improve
efﬁciency and reduce laboratory workload.
Methods: All of the patients who underwent a vasectomy from April 2012
toMarch 2013 were included. We analysed the time of the ﬁrst and second
sperm samples, the number of samples provided per patient and time to
clearance.
Results: 101 patients had a vasectomy and 6 were excluded. Of the 95 pa-
tients 34% gave 1 or no samples andonly 24%were cleared by20weeks. 25%
had 2 consecutive scanty results and only 8% gave a fresh sperm sample.Conclusions: A high proportion of patients are not sending any specimens,
while those that do often have to send multiple specimens due to scanty
results. We propose a simpler system to improve compliance and shorten
the time to clearance: 1 posted sample at 12 weeks followed by a fresh
sample if positive, in line with the EAU Guidelines 2012.
0641: READMISSION AND COMPLICATIONS FOLLOWING TRANSRECTAL
ULTRASOUND GUIDED PROSTATE BIOPSY
Luke McGuinness *, Manal Kumar. Wirral University Teaching Hospitals,
Merseyside, UK.
Introduction: Prostate cancer is the most commonly diagnosed cancer in
men in the UK. Transrectal ultrasound guided prostate biopsy (TRUSGPb)
forms the mainstay of diagnosis. Although considered low-risk serious
complications of bleeding and infection can result in hospitalisation and
mortality has been recorded. We evaluated our TRUSGPb over a 2yr period
and those admitted to hospital within 30 days with a biopsy related
complication.
Methods: A total of 810 patients underwent TRUSGPb in a two-year
period. Clinical coding computer systems identiﬁed those patients
admitted within 30 days. Clinical notes were used to ascertain reason for
admission and any biopsy related morbidity.
Results: Of the 810 patients undergoing biopsy 44 (5.4%) were admitted
within 30 days. Thirty (3.7%) were admitted with a TRUSGPb related
morbidity. The average time from biopsy to admission was 6 days and the
average length of stay was 3 days. Nine (1.1%) were admitted with infec-
tion, eight (1.0%) with urinary retention, seven (0.86%) with haematuria,
four (0.49%) with rectal bleeding and 2 (0.25%) with blocked urethral
catheter.
Conclusions: Our incidence of TRUSGPb related complications requiring
hospitalisation is 3.7% with infection and bleeding predominating. No mor-
tality was recorded indicating TRUSGPb continues to be a safe procedure.
0748: HOW SAFE IS IT NOT TO FOLLOW UP BOSNIAK 2 CYSTS?
Tsong Kwong *, Dev Gulur, Margerat Lyttle, Suzanne Amin,
Shankar Chandrasekhran, Andrew Baird, Mahmoud Elfar. Aintree
University Hospital, Liverpool, UK.
Introduction: Bosniak 2 renal cysts have been a subject of much debate
regarding follow up because of their malignant potential. There is a paucity
of published data on long term follow up and if they need it.
Methods: We reviewed the details of 56 patients who were prospectively
followed up for incidentally detected Bosniak type 2 cysts since 2007. Of the
56 patients 34 patients were included in the analysis. The others were lost to
follow up or died before 5 years. All the patients had an initial CT followed by
an annual USS. Mean agewas 69 years.19 weremale and 15 female patients.
Results: After a mean follow up was 5 years, the cysts in all the patients
have remained stable with no change in Bosniak classiﬁcation. There was a
slight increase in the cyst dimensions in 4 and decrease in 2 patients. All
the patients have now been discharged.
Conclusions: Our study has shown that all Bosniak 2 cysts have remained
unchanged over 5 years suggesting that they do not necessarily need
follow up provided a baseline pre and post-contrast CT has been per-
formed to accurately characterize them.
0776: EARLY OUTCOMES FOR THE FIRST PATIENTS WITHIN A 2-ARM
RANDOMIZED AND PARALLEL SLING-VERSUS-SPHINCTER FEASIBILITY
PROTOCOL
Antoine Kass-Iliyya *, Ishaan Chaudhury, Rizwan Hamid,
Daniella E. Andrich, Tamsin J. Greenwell, Julian R. Shah,
Jeremy L. Ockrim. University College London Hospitals, London, UK.
Introduction: Surgical options for men with stress urinary incontinence
(SUI) after radical prostatectomy are male sling or artiﬁcial urinary
sphincter (AUS). No randomized controlled trials are available to compare
these interventions. The Sling-versus-Sphincter (SVS) feasibility protocol
was designed to assess potential for a randomized multicenter study.
Methods: All post prostatectomy SUI patients referred from Feb-Oct 2013
were assessed for eligibility. Objective assessment included 24h pad
weight and urodynamics. Subjective assessment was based on self-re-
ported questionnaires (ICIQMLUTS, EQ5D, PGI-I). Severe incontinence was
considered pad weight >400mls. Patients were treated with the
AMSAdVance sling or AMS800 AUS.
